[
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-1",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#definitiongeneral444529",
    "clean_content": "Definition / general\n\n* Heterogeneous group of nonneoplastic proliferations that mimic B cell lymphomas and affect lymphoid tissue in nodal or extranodal sites"
  },
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-2",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#essentialfeatures444530",
    "clean_content": "Essential features\n\n* Heterogeneous group of nonneoplastic proliferations that mimic B cell lymphomas and affect lymphoid tissue in nodal or extranodal sites* 3 different main patterns\n    + Nodal and extranodal follicular proliferations+ Nodal and extranodal nodular proliferations+ Nodal and extranodal immunoblastic proliferations"
  },
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-3",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Nodal follicular / nodular proliferations",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#nodalfollicularnodularproliferations444534",
    "clean_content": "Nodal follicular / nodular proliferations\n\n**Florid follicular hyperplasia** ([Hematol Oncol Clin North Am 2009;23:729](19577167))\n\n* Increased number of widely spaced primary and secondary follicles\n  + Florid cases usually involve medulla* Follicles show uneven size and shape* Hyperplastic germinal centers (GC) comprise a mixture of centroblasts and centrocytes with brisk mitoses, reactive T cells, follicular dendritic cells (FDCs) and tingible body macrophages ([Ann Diagn Pathol 2020;44:151421](31751845))\n      + B lymphocytes\n        - Centroblasts\n          * Mainly in the dark zone of GC* 3 - 4x size of small lymphocytes* Large vesicular nuclei, 1 - 3 peripheral nucleoli- Centrocytes\n            * Mainly in the light zone of GC* Small to intermediate sized cells with cleaved, hyperchromatic nuclei and small or absent nucleolus- Both centroblasts and centrocytes are BCL6+, CD10+, LMO2+, HGAL / GCET+, OCT2++ T lymphocytes\n          - Small and round- CD3+ and BCL2+- Subset of T helper cells (TFH): polarized CD4+, PD-1 / CD279+, BCL6+, CD10+, CXCL13+, ICOS++ Follicular dendritic cells (FDCs)\n            - Few (usually ~1%)- 2 square shaped and adjacent nuclei (kissing cells) with vesicular chromatin\n                * May display small nucleolus- Long cytoplasmic processes- CD21+, CD23+ or CD35++ Tingible body macrophages\n              - Display oval or twisted vesicular nuclei- Abundant pale cytoplasm containing karyorrhectic nuclei- Impart a starry sky pattern when prominent- CD4+, CD68+ or CD163+* Well developed mantle zones* Distinction from germinal centers\n          + Composed predominantly of small lymphocytes and IgD+* No or limited extension outside the capsule into perinodal soft tissue* Location can suggest underlying disease and additional workup is necessary to confirm the diagnosis ([Pediatr Clin North Am 2002;49:1009](12430623))\n              + Cervical: infectious mononucleosis+ Posterior cervical: toxoplasmosis+ Parotid, submaxillary, epitrochlear: HIV infection+ Cervical and axillary: cat scratch disease, dermatopathic lymphadenitis+ Inguinal: sexually transmitted diseases* Immunoarchitecture ([Ann Diagn Pathol 2020;44:151421](31751845), [Clin Lab Med 2021;41:433](34304774))\n                + Lymphoid follicles express B cell antigens+ Primary follicles\n                    - Small lymphocytes- BCL2+, Ki67 (usually < 10%), BCL6- and CD10-+ Secondary follicles\n                      - GCs are BCL2-\n                        * TFH cells: subset of T cells in germinal centers are BCL2 positive and occasionally are increased\n                          + May mimic follicular lymphoma* Pediatric type follicular lymphoma (FL) is BCL2 negative\n                            + FOXP1 is positive in GC cells of pediatric FL ([Virchows Arch 2019;475:771](31686194))- High proliferation Ki67\n                          * Polarization (centroblast rich dark zone and a centrocyte rich pale zone)* Low Ki67 proliferation rate within a germinal center should always be considered atypical and suspicious for follicular lymphoma- BCL6+ and CD10+ are restricted to GCs, minimal in interfollicular areas* Flow cytometry\n                  + Polytypic B cells; CD10+, T cell antigens-* Polymerase chain reaction (PCR)\n                    + Polyclonal immunoglobulin heavy chain gene rearrangement+ No evidence of t(14;18)(q32;q21) or *IGH::BCL2* fusion\n\n  \n**Progressive transformation of germinal centers (PTGC)** ([Virchows Arch 2019;475:771](31686194))\n\n* Single or few large (4 - 5x normal) lymphoid follicles with mantle cells extensively indenting into GCs* Background lymph node exhibits reactive follicular hyperplasia (RFH)* Negative for rosetting by PD-1+ cells (TFH) around large B cells* GCs remnants rarely show tingible body macrophages* Morphological changes seem to proceed gradually\n          + Early stages show hyperplastic GCs+ Fusion of GCs within one single follicle (usually 2 - 3x size)+ Inward migration of mantle zone small B cells into the germinal center+ Later stages: dissolution of GCs results in islands or scattered centrocytes and centroblasts with follicular dendritic cells among small mantle zone B cells* Immunoarchitecture\n            + Preserved B and T cell compartments of lymph node and prominent follicular pattern+ Both GC and mantle zone cells express pan-B cell antigens+ Mantle cells: BCL2+, IgD+, BCL6- and CD10-+ Disrupted GCs: BCL6+, CD10+, BCL2- and IgD-+ CD21, CD23 or CD35 show disruption of FDCs meshwork+ IgG4+ plasma cells: ~40 - 50% of cases* Flow cytometry\n              + Polytypic B cells* Genetic testing\n                + Polyclonal *IGH* rearrangements\n\n  \n**Hyaline vascular Castleman disease (HVCD)**\n\n* Young adults ([Blood 2017;129:1658](28100459))\n  + Usually < 30 years old+ Can also affect children* Numerous follicles in cortex and medulla of lymph node or extramedullary sites* Obliteration of subcapsular and interfollicular sinuses* â‰¥ 2 germinal centers in follicle (also known as twinning)* Follicles typically large with regressed (or involuted) germinal centers\n          + Mostly composed of FDCs with few lymphocytes+ Mantle zones prominent+ FDCs often hyperplastic and can show dysplasia* Many follicles show so called lollipop features\n            + Concentric rings of mantle zone lymphocytes (onion skin appearance)+ Sclerotic blood vessels radially traversing into germinal center* Interfollicular or stromal component is also important ([J Clin Exp Hematop 2022;62:60](35474035))\n              + Increased number of high endothelial venules with hyalinized walls+ Stromal component can predominate with only a few hyaline vascular follicles* Clusters of plasmacytoid dendritic cells can occur* Plasma cells and immunoblasts are not abundant in HVCD\n                  + More common and abundant in plasma cell Castleman disease (PCCD)* Immunohistochemistry\n                    + HHV8 is absent+ Polytypic B, T cells and plasma cells+ Increased FDCs in involuted germinal centers\n                          - CD21+, CD23+, CD35+ or EGFR++ Dysplastic FDCs often stain variably for FDC markers* Differential diagnosis\n                      + Classic Hodgkin lymphoma concurrent with Castleman disease ([Virchows Arch 2020;477:437](32152665))\n                        - Diagnosis is established upon identification of Hodgkin Reed-Sternberg (HRS) cells with usual phenotype+ Castleman-like follicles in infectious lymphadenopathies\n                          - Changes are focal and sinuses are open\n\n  \n\n|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Table 1. Differential diagnosis between florid follicular hyperplasia and B cell lymphomas with follicular formation**| Feature Florid follicular hyperplasia Follicular lymphoma Marginal zone lymphoma Mantle cell lymphoma, mantle zone pattern|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Follicles Enlarged, with prominent GCs and distinct mantle zones Variably sized surrounded by faint mantle zones Nodules with remnants of GCs surrounded by monocytoid cells Thickened mantle zones|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Density Low, widely spaced Back to back Variable; may be confluent Variable|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Size Uneven Uniform Variable Uniform|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Borders of GC Sharp, well defined Fainted, crack artifact Blurry Sharp, well defined|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Distribution Cortical predominance; florid cases involve medulla Cortex and medulla Cortex and medulla Even distribution throughout cortex and medulla|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Extension to perinodal fat Absent or unusual Often present Often present Uncommon|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Mantle zone Present, well developed Attenuated to absent Generally absent Expanded in mantle zone pattern|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Marginal zone Can be hyperplastic Absent Expanded, may coalesce Absent|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Germinal center cells Colonized by monocytoid cells Absent|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Tingible body macrophages Present and common Decreased or absent Decreased or absent Variable|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Polarization Present Absent Absent Variable|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Cytologic features Centroblasts, centrocytes and macrophages Centroblasts and centrocytes in various proportions Monocytoid and plasmacytoid; scattered large cells Small and intermediate centrocyte-like cells; few large cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Immunoarchitecture |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | BCL2 Negative in GCs Positive in germinal centers of FL grades 1 - 2; 50% in FL grade 3 Positive in neoplastic cells; GC remnants are negative Positive in mantle zones|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | BCL6, CD10 Positive, restricted to GCs Positive in GCs and interfollicular areas Negative, GC remnants positive Positive, restricted to GCs|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Ki67 High proliferation rate; polarized in GCs Low, nonpolarized Low, nonpolarized Variable in mantle zones|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CD21, CD23, CD35 FDC meshworks preserved FDC meshworks preserved Distorted FDC meshworks FDC meshworks preserved|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Common positive markers BCL6, LMO2, OCT2, HGAL CD10, BCL2, BCL6, LMO2 CD43, MNDA, CD5-/+ Cyclin D1, SOX11, CD5|  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Common negative markers CD3, BCL2 CD5, cyclin D1 CD10, cyclin D1, SOX11 CD10-, CD23- in mantle zones|  |  |  |  |  | | --- | --- | --- | --- | --- | | Flow cytometry Polytypic Monotypic surface Ig; CD10 positive Monotypic surface Ig; CD10 neg; CD5 neg or weak Monotypic surface Ig; CD5 positive | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |\n\n  \n  \n\n|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Table 2. Differential diagnosis between progressive transformation of germinal centers and lymphomas with large nodules**| Feature Progressive transformation of germinal center Nodular predominant Hodgkin lymphoma (patterns A / B) Lymphocyte rich classic Hodgkin lymphoma, nodular variant|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Follicles |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Size Scattered large nodules Nodules larger than PTGC Moderately enlarged|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Germinal centers Variably disrupted or involuted Absent Present within neoplastic nodules|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Centrocytes and centroblasts Decreased; scattered, BCL2- Absent In residual GCs|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Mantle zone cells Inward growth into GCs, BCL2+ and IgD+ Absent Expanded|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Reactive follicular hyperplasia Present at background Absent or focal Absent or focal|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Immunoarchitecture |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | T follicular helper cells rosettes (PD-1+) Absent Present May be present|  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | IgG4+ plasma cells In 40 - 50% of cases Absent Absent|  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | | Large B cells Rare immunoblasts LP cells (popcorn cells) Present, HRS cells|  |  |  |  | | --- | --- | --- | --- | | Immunophenotype IgG+ CD20+, CD45+, OCT2+, EMA+/-, PAX5+ strong, IgD-/+ CD30+, CD45-, CD15+, PAX5+ dim, OCT2-, EMA-, CD20- | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |"
  },
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-4",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Nodal immunoblastic proliferations",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#nodalimmunoblasticproliferations444535",
    "clean_content": "Nodal immunoblastic proliferations\n\n**Infectious mononucleosis** ([Semin Diagn Pathol 2018;35:54](29174725), [Virchows Arch 2019;475:771](31686194))\n\n* Caused by acute Epstein-Barr virus (EBV) infection* Histologic changes are variable and depend on disease duration\n    + Early stage: reactive follicles, with mild paracortical expansion+ Progression: follicles sparse due to interfollicular expansion+ Advanced stage: follicles may become effaced, with interfollicular expansion* Interfollicular areas with numerous immunoblasts or mixed infiltrate\n      + Immunoblasts can be dispersed or abundant+ Lymphocytes range from small to intermediate and large in size+ Plasma cells, plasmacytoid cells and histiocytes are variably present, less frequently accompanied by eosinophils+ Sinuses are regularly occupied by immunoblasts, monocytoid B cells and histiocytes* Immunoblasts can be binucleated, mimicking HRS\n        + Intact nodal architecture admixed with B and T immunoblasts are indicative of a reactive process* Focal necrosis may be present* Immunohistochemistry\n            + HRS-like cells are CD45+, CD15-, CD30+ (weak) admixed with B and T immunoblasts+ EBV latency type 3 ([Semin Diagn Pathol 2018;35:54](29174725))\n                - EBV encoded RNA (EBER) present in numerous infected cells, ranging from small and intermediate lymphocytes to HRS-like immunoblasts- EBNA1+, EBNA2 variable and EBNA3+- LMP1+ and LMP2++ Most lymphocytes in the background are CD8+, TIA1+\n\n  \n**Herpesvirus lymphadenitis** ([Virchows Arch 2019;475:771](31686194))\n\n* Uncommon complication from either primary exposure or reactivation (more common)* Prominent immunoblastic paracortical hyperplasia\n    + Similar to infectious mononucleosis* Sharply circumscribed areas of necrosis and sinus histiocytosis* Adjacent to areas of necrosis\n        + Multinucleated cells with ground glass chromatin and intranuclear viral inclusions (halo)* Herpes simplex virus (HSV) immunohistochemistry confirms the diagnosis\n\n  \n**Cytomegalovirus lymphadenitis** ([Virchows Arch 2019;475:771](31686194))\n\n* Morphologic features overlapping with those described in other viral infections* Monocytoid B cell hyperplasia is frequent* Characteristic owl eye central intranuclear inclusions with a halo* Cells infected with cytomegalovirus (CMV) often are T cells or endothelial cells* Diagnosis can be established utilizing CMV immunohistochemical stain\n\n  \n\n|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Table 3. Differential diagnosis between nodal B cell immunoblastic proliferation and lymphomas**| Feature Infectious mononucleosis Classic Hodgkin lymphoma Diffuse large B cell lymphoma, EBV+|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Nodal compartment Paracortical Diffuse effacement Diffuse effacement|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Neoplastic cells Not present Scattered large cells; confluent in nodular sclerosis syncytial variant Abundant large cells; diffuse pattern|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Background lymphocytes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | B cells Small to intermediate Small Small|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | T cells CD8+, small to intermediate CD4+, small CD8+, small|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Monocytoid B cells hyperplasia Often present Absent Absent|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Plasma cells Variably present Few Not frequent|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Histiocytes Variably present Variable Variable|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Eosinophils Rare Present, often abundant May be present|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Necrosis Focally present Often present in nodular sclerosis subtype May be present|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Immunoarchitecture |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | EBV latency type Type III Type II Type I|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | EBER Positive in most cells Positive in HRS cells Positive in large cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | LMP1 Positive, fewer small and large cells (less sensitive) Restricted to HRS cells in positive cases If positive, restricted to large neoplastic cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | EBNA2 Mostly positive Negative Negative|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | EBNA3 Positive Negative Negative|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CD20 Positive in large cells Faint reactivity in HRS cells in ~20% of cases Positive in large cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CD3 Positive in small lymphocytes Negative in HRS cells Negative in large cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CD30 Positive in HRS-like cells, usually dim Positive in HRS cells, strong May be positive in neoplastic cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CD45 Positive in most cells Negative in HRS cells Positive in neoplastic cells|  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CD4, PD-1, ICOS, CXCL13 Negative in immunoblasts Negative in HRS cells Negative in neoplastic cells|  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | | CD21 Present only in GCs Present only in residual GCs Absent|  |  |  |  | | --- | --- | --- | --- | | Diagnostic molecular testing Polyclonal B and T cells Polyclonal B and T cells Monoclonal *IGH* gene rearrangements | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |"
  },
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-5",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Extranodal follicular proliferations",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#extranodalfollicularproliferations444536",
    "clean_content": "Extranodal follicular proliferations\n\n**Florid reactive lymphoid hyperplasia**\n\n* Most cases represent reactive tertiary lymphoid tissue and may be associated either with an infectious agent, autoimmune phenomena or chronic repetitive trauma; these processes may lead to extranodal marginal zone lymphoma ([Pathology 2020;52:15](31757436))\n  + Stomach: *Helicobacter pylori*+ Skin: *Borrelia burgdorferi* + Conjunctiva: *Chlamydia psittaci*+ Cervix: *Chlamydia trachomatis*+ Small intestine: *Campylobacter jejuni*+ Lung: *Achromobacter xylosoxidans*+ Gallbladder: extrahepatic biliary obstruction+ Thyroid: Hashimoto thyroiditis+ Salivary gland: SjÃ¶gren syndrome* Differential diagnosis with marginal zone lymphoma can be challenging in some cases\n    + Cutaneous reactive lymphoid hyperplasia must be also distinguished from primary cutaneous follicular center lymphoma (see [table](https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#reactbcellrichtable4)) ([Arch Pathol Lab Med 2018;142:1313](30407851))+ Florid reactive lymphoid hyperplasia of the female reproductive tract\n        - Cervix is the most frequent affected site, followed by endometrium and vulva ([Int J Gynecol Pathol 2022;41:459](34723846))* Most cases show lymphoid infiltrate with superficial distribution, with or without ulceration* Architecture varies from patchy and nodular to diffuse, with secondary follicles in most cases\n        + Tends to imitate lymph nodes organization, with a B follicular and T interfollicular compartments* Cytologically composed by small lymphocytes and polytypic plasma cells, with variable number of granulocytes and histiocytes in the background* Scattered large CD30+ immunoblasts are present in the majority of cases* Clonal *IGH* rearrangement is not uncommon, although patients are free of lymphoma on follow up ([Arch Pathol Lab Med 2018;142:1313](30407851))\n\n  \n\n\n|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Table 4. Differential diagnosis between cutaneous follicular hyperplasia and B cell lymphomas**| Feature Reactive follicular hyperplasia Primary cutaneous follicular center lymphoma Primary cutaneous marginal zone lymphoma|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Infiltrate Denser in superficial dermis, wedge shaped Denser in deep dermis, Grenz zone Vertical orientation around follicles|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Follicular architecture Present, uneven shapes and size Follicular or diffuse pattern Pale nodules, some residual germinal centers|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Mantle zone Present, well developed Attenuated to absent Absent|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Marginal zone Generally absent Absent Expanded, may coalesce|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Germinal center cells Colonized by monocytoid cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Tingible body macrophages Present Absent Present in GC remnants|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Polarization Present Absent Absent|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Cytologic features Centrocytes and centroblasts Centroblasts and centrocytes Monocytoid cells, few large cells; plasma cells|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Immunoarchitecture B and T compartments preserved Effaced, B cell predominant Effaced, B cell predominant|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | BCL2 Negative in germinal centers Negative in germinal centers Positive in neoplastic cells; GC remnants are negative|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | BCL6 Positive, restricted to GCs Positive in both GCs and interfollicular areas Negative, GC remnants positive|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Ki67 High and polarized in GCs Low, nonpolarized Low, nonpolarized|  |  |  |  |  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | CD21, CD23, CD35 FDC meshworks preserved FDC meshworks preserved Distorted FDC meshworks|  |  |  |  |  |  |  |  | | --- | --- | --- | --- | --- | --- | --- | --- | | Light chain restriction Absent May be present Present in plasmacytoid lymphocytes or mature plasma cells|  |  |  |  | | --- | --- | --- | --- | | Positive IgH / IgK clonality assays No Yes Yes | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |"
  },
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-6",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Extranodal immunoblastic proliferations",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#extranodalimmunoblasticproliferations444537",
    "clean_content": "Extranodal immunoblastic proliferations\n\n**EBV positive mucocutaneous ulcer** ([Surg Pathol Clin 2023;16:213](37149357))\n\n* Lymphoproliferative disorder characterized by EBV+ large B cells / Reed-Sternberg-like cells (RS-like cells) cells* Oral mucosa is most common site, followed by skin\n    + Multiple small lesions within same anatomic region can occur* No systemic symptoms, lymphadenopathy, hepatosplenomegaly or bone marrow involvement* Well circumscribed superficial ulcer with a subjacent polymorphous infiltrate* Deep base shows a sharp demarcation by a dense rim of small lymphocytes* Angioinvasion and high proliferation index may be present* Monoclonal *IGH* or TCR gene rearrangements can occur in up to a third of cases* Immunohistochemistry\n                + HRS-like cells: CD45+, CD15- and CD30+ (usually weak)+ Background: B and T cells+ EBV latency type 3 ([Semin Diagn Pathol 2018;35:54](29174725))\n                      - EBV encoded RNA (EBER) present in numerous infected cells, ranging from small and intermediate lymphocytes to HRS-like immunoblasts- LMP1+, EBNA2++ Basal rim of T cells are CD8+"
  },
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-7",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#casereports444538",
    "clean_content": "Case reports\n\n* 24 year old man with follicular lymphoid hyperplasia with aggressive behavior in maxilla ([Oral Maxillofac Surg 2017;21:475](29067544))* 40 year old man with infectious mononucleosis that presented as a lymphadenopathy with geographic necrosis ([Pathol Res Pract 2004;200:53](15157051))* 57 year old woman with idiopathic multicentric Castleman disease (TAFRO subtype) ([Br J Haematol 2022;196:461](34618353))* 70 year old woman with atypical follicular hyperplasia after COVID-19 booster ([Virchows Arch 2023;482:905](36098816))"
  },
  {
    "id": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt-8",
    "source_document": "reactive-b-cell-rich-lymphoid-proliferations-that-can-mimic-lymphoma_44809_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivebcellrichlymphprolif.html#microscopichistologicimages444539",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Roberto N. Miranda, M.D. and Roman Segura-Rivera, M.D.  \n\n[![Reactive follicular hyperplasia](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera01.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera01.jpg)\n\nReactive follicular hyperplasia\n\n[![Polarized Ki67](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera02.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera02.jpg)\n\nPolarized Ki67\n\n[![Follicular lymphoma](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera03.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera03.jpg)\n\nFollicular lymphoma\n\n[![Nonpolarized Ki67](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera04.jpg)\n\nNonpolarized Ki67\n\n[![Nodal marginal zone lymphoma](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera05.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera05.jpg)\n\nNodal marginal zone lymphoma\n\n[![Monocytoid cytology](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera06.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera06.jpg)\n\nMonocytoid cytology\n\n  \n\n[![MCL with mantle zone pattern](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera07.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera07.jpg)\n\nMantle cell lymphoma (MCL) with mantle zone pattern\n\n[![Cyclin D1 (mantle pattern) in MCL](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera08.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera08.jpg)\n\nCyclin D1 (mantle pattern) in MCL\n\n[![Progressive transformation of germinal centers](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera09.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera09.jpg)\n\nProgressive transformation of germinal centers\n\n[![CD20 in PTGC](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera10.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera10.jpg)\n\nCD20 in PTGC\n\n[![Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera11.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera11.jpg)\n\nNLPHL\n\n[![LP cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera12.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera12.jpg)\n\nLP cells\n\n  \n\n[![Rosetting CD3+ lymphocytes](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera13.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera13.jpg)\n\nRosetting CD3+ lymphocytes\n\n[![Castleman disease, hyaline vascular variant](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera14.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera14.jpg)\n\nCastleman disease, hyaline vascular variant\n\n[![Germinal center in HVCD](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera15.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera15.jpg)\n\nGerminal center in HVCD\n\n[![Interfollicular expansion](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera16.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera16.jpg)\n\nInterfollicular expansion\n\n[![Immunoblasts](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera17.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera17.jpg)\n\nImmunoblasts\n\n[![Infectious mononucleosis, EBER](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera18.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera18.jpg)\n\nInfectious mononucleosis, EBER\n\n  \n\n[![EBV positive diffuse large B cell lymphoma](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera19.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera19.jpg)\n\nEBV positive diffuse large B cell lymphoma\n\n[![EBER positivity in EBV positive diffuse large B cell lymphoma](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera20.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera20.jpg)\n\nEBER positivity in EBV positive diffuse large B cell lymphoma\n\n[![Mixed cellularity classic Hodgkin lymphoma](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera21.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera21.jpg)\n\nMixed cellularity classic Hodgkin lymphoma (MCCHL)\n\n[![EBER positivity in mixed cellularity classic Hodgkin lymphoma](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera22.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivebcellrichlymphprolifmirandasegurarivera22.jpg)\n\nEBER positivity in MCCHL"
  }
]